Jump to navigation
SRI Biosciences - Stanford Drug Discovery and Development Program to Explore New Molecular Target for Treatment of Triple Negative Breast Cancer - March 23, 2016
Balancing Widespread Use and Positive Learning Impacts of Educational Technology
Science and Engineering Indicators Give Policy Makers Better Information for Data-Based Decisions
SRI Identity™ will showcase an updated product lineup with live booth demonstrations at IFSEC 2016.
SRI Biosciences researchers will be speaking and presenting at the Liquid Biopsy Summit.
SRI's Center for Vision Technologies will be highlighting its expanding at CVPR.
Press Release Archive
SRI's YouTube Channel
Material Usage Permissions